Shares of Johnson & Johnson (JNJ) are rising more than 5% Thursday morning after reporting better-than-expected second-quarter results.
Earnings for the second quarter rose to $5.144 billion or $1.96 per share from $4.814 billion or $1.80 per share in the same quarter a year ago.
Excluding one-items, earnings were $7.358 billion or $2.80 per share, that beat the average estimate of analysts polled by Thomson-Reuters of $2.62 per share.
Quarterly sales increased 6.3% to $25.53 billion from $24.02 billion last year. The consensus estimate was for $24.63 billion.
Looking forward, the company has raised its full-year sales outlook to $98.8 billion - $99.8 billion from $97.9 billion - $98.9 billion provided earlier. Adjusted EPS outlook has been raised to $10.70 - $10.80 from $10.60 - $10.70
Analysts expect the company to report earnings of $1.065 per share on revenue of $98.96 billion for the year.
JNJ, currently at $167.08 has traded in the range of $150.11 - 181.04 in the last 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.